UMIN ID: UMIN000054072
Registered date:05/04/2024
Combination therapy with cryoablation and radiofrequency ablation for lung cancer
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Primary lung cancer and metastatic lung cancer |
Date of first enrollment | 2024/04/05 |
Target sample size | 500 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | For lung cancer, after cryoablation, the cryoablation probe is replaced by radiofrequency probe, followed by cryoablation. |
Outcome(s)
Primary Outcome | Local control rate and survival rate more than 3 years after the treatment |
---|---|
Secondary Outcome | Short- and long-term complications after treatment |
Key inclusion & exclusion criteria
Age minimum | 10years-old |
---|---|
Age maximum | 100years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1. Severe pulmonary failure. 2. Life expectancy is predicted to be less than 6 months. 3. Active interstitial pneumonia. |
Related Information
Primary Sponsor | Kashiwa Kousei General Hospital |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Kashiwa Kousei General Hospital |
Secondary ID(s) |
Contact
public contact | |
Name | Hiroaki Nomori |
Address | Shikoda 617, Kashiwa city, Chiba prefecture Japan 277-8551 |
Telephone | 0471451111 |
hnomori@qk9.so-net.ne.jp | |
Affiliation | Kashiwa Kousei General Hospital Department of thoracic surgery |
scientific contact | |
Name | Hiroaki Nomori |
Address | Shikoda 617, Kashiwa-city, Chiba prefecture |
Telephone | +81471451111 |
hnomori@qk9.so-net.ne.jp | |
Affiliation | Kashiwa Kousei General Hospital Department of thoracic surgery |